The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis

Cakan M., Ayaz N., Karadag Ş. G., Tanatar A.

NORTHERN CLINICS OF ISTANBUL, cilt.7, sa.2, ss.118-123, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.14744/nci.2019.57873
  • Dergi Adı: NORTHERN CLINICS OF ISTANBUL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.118-123
  • Anahtar Kelimeler: Biologics, juvenile idiopathic arthritis, tuberculosis, LATENT TUBERCULOSIS INFECTION, SKIN-TEST, CHILDREN, METHOTREXATE, RATES, RISK
  • İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Juvenile idiopathic arthritis (JIA) is the most common cause of chronic arthritis in children. Biologics have changed the faith of children with rheumatic diseases. The main objective of this study was to demonstrate the rate of usage, efficacy and safety of biologics in JIA subtypes.